teicoplanin for the treatment of G + bacterial infections

Third Affiliated Hospital of Sun Yat-sen Chang-day care such as evaluation of teicoplanin treatment of G + bacteria infection efficacy and safety, the use of randomized controlled and open trials to vancomycin as the control. Completed cases, 60 cases in which the test group of 30 patients, teicoplanin 0.2 to 0.4 grams a day, intravenously; the control group of 30 patients, vancomycin 0.5 g, 3 times a day intravenously. Treatment lasted 7 to 14 days. Results, the test group cure rate, efficient bacterial clearance rates were 50%, 80% and 83.3% in the control group were 46.7%, 76.7% and 76.7%, no significant difference between the two groups. Adverse reaction rates were 10% and 13.3%, no significant difference between the two groups. From this view, teicoplanin therapy safe and effective G + bacterial infection. Read more：http://www.acid-lactic-bacteria.com/bulk-drug/Teicoplanin/